The REMS Industry Consortium fosters collaboration and innovation to advance patient safety, appropriate access, and best practices in REMS related drug and biologic risk management.
The REMS Industry Consortium is a nonprofit organization bringing together the perspectives of organizations that sell, or anticipate selling, prescription drugs or biologics subject to Risk Evaluation and Mitigation Strategies (REMS).
The REMS Industry Consortium understands the need for REMS professionals to further develop their knowledge in the field and resources specifically tailored to them. We are excited to announce the launch of the RIC's REMS 101 course. The REMS 101 course was developed by REMS Industry Professionals on the RIC as a tool to be sued by professionals to learn about REMS.